Shopping Cart 0
Cart Subtotal
AED 0

Novozymes AS (NZYM B)-Financial and Strategic SWOT Analysis Review

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
AED 459

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
AED 918

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
AED 1376

Details

Novozymes AS (NZYM B)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company operations and business divisions.

Corporate strategy-Analyst summarization of the company business strategy.

SWOT Analysis-A detailed analysis of the company strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novozymes A/S (Novozymes) is a biotech company that produces and sells industrial enzymes and microorganisms. The company develops, produces and distributes enzymes for detergent, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment. Novozymes provides various biopharmaceutical ingredients for the pharmaceutical industry. The company caters products to various industries such as household care, agriculture, biopharmaceuticals, bioenergy, food and beverages, pulp and paper, leather, wastewater and textiles. It has operational presence in various countries such as Denmark, China, India and the US among other countries. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS Key Recent Developments

Jun 27,2017: DONG Energy: One of the largest power stations in Denmark can phase out coal

Mar 23,2017: Residues from Novo Nordisk and Novozymes to be converted into biogas

Dec 05,2016: Monsanto Company and Novozymes launch corn inoculant Acceleron B-300 SAT

Jun 30,2016: Novozymes to deliver enzymes for Dong Energy REnescience plant in UK

Jun 29,2016: Novozymes and DONG Energy enter into agreement on biological waste sorting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Novozymes A/S-Key Facts 5

Novozymes A/S-Key Employees 6

Novozymes A/S-Key Employee Biographies 7

Novozymes A/S-Major Products and Services 8

Novozymes A/S-History 9

Novozymes A/S-Company Statement 12

Novozymes A/S-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 17

Novozymes A/S-Business Description 17

Novozymes A/S-Corporate Strategy 18

Novozymes A/S-SWOT Analysis 19

SWOT Analysis-Overview 19

Novozymes A/S-Strengths 19

Novozymes A/S-Weaknesses 20

Novozymes A/S-Opportunities 21

Novozymes A/S-Threats 22

Novozymes A/S-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Novozymes A/S, Recent Deals Summary 31

Section 4-Company's Recent Developments 32

Jun 27, 2017: DONG Energy: One of the largest power stations in Denmark can phase out coal 32

Mar 23, 2017: Residues from Novo Nordisk and Novozymes to be converted into biogas 33

Dec 05, 2016: Monsanto Company and Novozymes launch corn inoculant Acceleron B-300 SAT 35

Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 36

Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 37

Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 38

Jun 29, 2016: Novozymes and DONG Energy enter into agreement on biological waste sorting 39

Jan 19, 2016: Group Financial Statement for 2015: Novozymes 40

Jan 19, 2016: Novozymes separates its biopharma activities to form independent company 41

Section 5-Appendix 42

Methodology 42

Ratio Definitions 42

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Novozymes A/S, Performance Chart (2012-2016) 28

Novozymes A/S, Ratio Charts 30


List Of Table

List of Tables

Novozymes A/S, Key Facts 5

Novozymes A/S, Key Employees 6

Novozymes A/S, Key Employee Biographies 7

Novozymes A/S, Major Products and Services 8

Novozymes A/S, History 9

Novozymes A/S, Subsidiaries 14

Novozymes A/S, Key Competitors 23

Novozymes A/S, Ratios based on current share price 24

Novozymes A/S, Annual Ratios 25

Novozymes A/S, Annual Ratios (Cont...1) 26

Novozymes A/S, Annual Ratios (Cont...2) 27

Novozymes A/S, Interim Ratios 29

Novozymes A/S, Recent Deals Summary 31

Currency Codes 42

Capital Market Ratios 42

Equity Ratios 43

Profitability Ratios 43

Cost Ratios 44

Liquidity Ratios 44

Leverage Ratios 45

Efficiency Ratios 45

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Company Profile

Company Profile Title

Novozymes AS (NZYM B)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

Business description-A detailed description of the company operations and business divisions.

Corporate strategy-Analyst summarization of the company business strategy.

SWOT Analysis-A detailed analysis of the company strengths, weakness, opportunities and threats.

Company history-Progression of key events associated with the company.

Major products and services-A list of major products, services and brands of the company.

Key competitors-A list of key competitors to the company.

Key employees-A list of the key executives of the company.

Executive biographies-A brief summary of the executives' employment history.

Key operational heads-A list of personnel heading key departments/functions.

Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.

Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.

Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Novozymes A/S (Novozymes) is a biotech company that produces and sells industrial enzymes and microorganisms. The company develops, produces and distributes enzymes for detergent, technical, food and feed industries. It supplies a range of microorganisms for use in agriculture, industrial cleaning and wastewater treatment. Novozymes provides various biopharmaceutical ingredients for the pharmaceutical industry. The company caters products to various industries such as household care, agriculture, biopharmaceuticals, bioenergy, food and beverages, pulp and paper, leather, wastewater and textiles. It has operational presence in various countries such as Denmark, China, India and the US among other countries. Novozymes is headquartered in Bagsvaerd, Denmark.

Novozymes AS Key Recent Developments

Jun 27,2017: DONG Energy: One of the largest power stations in Denmark can phase out coal

Mar 23,2017: Residues from Novo Nordisk and Novozymes to be converted into biogas

Dec 05,2016: Monsanto Company and Novozymes launch corn inoculant Acceleron B-300 SAT

Jun 30,2016: Novozymes to deliver enzymes for Dong Energy REnescience plant in UK

Jun 29,2016: Novozymes and DONG Energy enter into agreement on biological waste sorting

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

The profile analyzes the company business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

The company core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 4

List of Figures 4

Section 1-About the Company 5

Novozymes A/S-Key Facts 5

Novozymes A/S-Key Employees 6

Novozymes A/S-Key Employee Biographies 7

Novozymes A/S-Major Products and Services 8

Novozymes A/S-History 9

Novozymes A/S-Company Statement 12

Novozymes A/S-Locations And Subsidiaries 14

Head Office 14

Other Locations & Subsidiaries 14

Section 2-Company Analysis 17

Novozymes A/S-Business Description 17

Novozymes A/S-Corporate Strategy 18

Novozymes A/S-SWOT Analysis 19

SWOT Analysis-Overview 19

Novozymes A/S-Strengths 19

Novozymes A/S-Weaknesses 20

Novozymes A/S-Opportunities 21

Novozymes A/S-Threats 22

Novozymes A/S-Key Competitors 23

Section 3-Company Financial Ratios 24

Financial Ratios-Capital Market Ratios 24

Financial Ratios-Annual Ratios 25

Performance Chart 28

Financial Performance 28

Financial Ratios-Interim Ratios 29

Financial Ratios-Ratio Charts 30

Novozymes A/S, Recent Deals Summary 31

Section 4-Company's Recent Developments 32

Jun 27, 2017: DONG Energy: One of the largest power stations in Denmark can phase out coal 32

Mar 23, 2017: Residues from Novo Nordisk and Novozymes to be converted into biogas 33

Dec 05, 2016: Monsanto Company and Novozymes launch corn inoculant Acceleron B-300 SAT 35

Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 36

Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 37

Jun 30, 2016: Novozymes to deliver enzymes for Dong Energy's REnescience plant in UK 38

Jun 29, 2016: Novozymes and DONG Energy enter into agreement on biological waste sorting 39

Jan 19, 2016: Group Financial Statement for 2015: Novozymes 40

Jan 19, 2016: Novozymes separates its biopharma activities to form independent company 41

Section 5-Appendix 42

Methodology 42

Ratio Definitions 42

About GlobalData 46

Contact Us 46

Disclaimer 46


List Of Figure

List of Figures

Novozymes A/S, Performance Chart (2012-2016) 28

Novozymes A/S, Ratio Charts 30


List Of Table

List of Tables

Novozymes A/S, Key Facts 5

Novozymes A/S, Key Employees 6

Novozymes A/S, Key Employee Biographies 7

Novozymes A/S, Major Products and Services 8

Novozymes A/S, History 9

Novozymes A/S, Subsidiaries 14

Novozymes A/S, Key Competitors 23

Novozymes A/S, Ratios based on current share price 24

Novozymes A/S, Annual Ratios 25

Novozymes A/S, Annual Ratios (Cont...1) 26

Novozymes A/S, Annual Ratios (Cont...2) 27

Novozymes A/S, Interim Ratios 29

Novozymes A/S, Recent Deals Summary 31

Currency Codes 42

Capital Market Ratios 42

Equity Ratios 43

Profitability Ratios 43

Cost Ratios 44

Liquidity Ratios 44

Leverage Ratios 45

Efficiency Ratios 45

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS